We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00741637
First Posted: August 26, 2008
Last Update Posted: March 30, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Vaccine Technologies Inc.
Siriraj Hospital
Information provided by (Responsible Party):
International Vaccine Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)